Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Meg McLachlin"'
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 44:142-147
Universal screening of endometrial cancer for underlying Lynch syndrome (LS) using DNA mismatch repair immunohistochemistry (MMR IHC) has been recommended. The objective of this study was to assess the feasibility and outcomes of using office endomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1dba6d6f7843f45fca9abbc4315ff11
https://doi.org/10.1016/j.jogc.2021.08.014
https://doi.org/10.1016/j.jogc.2021.08.014
Autor:
Lisa Vermij, Jan Jobsen, Mariel Brinkhuis, Suzan Roothaan, Alicia Leon-Castillo, Naveena Singh, Linda Mileshkin, Melanie Powell, Prafull Ghatage, Meg McLachlin, Alexandra Leary, Catherine Genestie, Hans Nijman, Ina Jürgenliemk-Schulz, Remi Nout, Vincent Smit, Stephanie de Boer, Carien Creutzberg, Nanda Horeweg, Tjalling Bosse
Publikováno v:
Endometrial cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccbc76a4b3f1d2386bba7379955f6427
https://doi.org/10.1136/ijgc-2022-esgo.214
https://doi.org/10.1136/ijgc-2022-esgo.214
Autor:
Emily A. Goebel, Jennifer Kerkhof, Oleksandra Dzyubak, C. Meg McLachlin, Jacob McGee, Bekim Sadikovic
Publikováno v:
Obstetrics & Gynaecology Publications
Genes; Volume 13; Issue 8; Pages: 1398
Genes; Volume 13; Issue 8; Pages: 1398
Despite advances in treatment, prognosis for most patients with high-grade serous carcinoma (HGSC) remains poor. Genomic alterations in the homologous recombination (HR) pathway are used for cancer risk assessment and render tumours sensitive to plat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2536e3c344df43fc960298c5d303f13e
https://ir.lib.uwo.ca/context/obsgynpub/article/1097/viewcontent/genes_13_01398.pdf
https://ir.lib.uwo.ca/context/obsgynpub/article/1097/viewcontent/genes_13_01398.pdf
Autor:
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, Melanie E. Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Leary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, N. Horeweg, S.M. de Boer, C.L. Creutzberg, T. Bosse, V.T.H.B.M. Smit, J. Kroep, R.A. Nout, H.W. Nijman, M. de Bruyn, M.E. Powell, N. Singh, H.C. Kitchener, E. Crosbie, R. Edmondson, D.N. Church, A. Leary, L. Mileshkin, P.M. Pollock, H. MacKay
Publikováno v:
Modern Pathology, 35(10), 1475-1483. SPRINGERNATURE
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and the most likely to benefit from adjuvant chemo(radio)therapy. P53abn EC ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081e838f95f1846415ec67f616f3afc4
https://hdl.handle.net/1887/3505651
https://hdl.handle.net/1887/3505651
Autor:
Meg McLachlin, C., Mai, Verna, Murphy, Joan, Fung-Kee-Fung, Michael, Chambers, Alexandra, Oliver, Thomas K.
Publikováno v:
In Journal of Obstetrics and Gynaecology Canada April 2007 29(4):344-353
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 43:555-556
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aacb26f8330139883b364e342bbab3cb
https://doi.org/10.1016/j.jogc.2021.01.003
https://doi.org/10.1016/j.jogc.2021.01.003
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 38(3)
There are no widely accepted pathologic criteria for reporting endometrial samples with limited tissue and no consensus on the clinical follow-up of patients with these samples. Our study compares clinicopathologic outcomes and determines reporting c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c57815b3f7ff98cc437ff246befb41
https://pubmed.ncbi.nlm.nih.gov/29750710
https://pubmed.ncbi.nlm.nih.gov/29750710
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 37:245-251
Objective To describe performance measures related to colposcopic examinations in Canadian cervical cancer screening programs; specifically, time to colposcopy, histological investigation rate, and agreement between cytology and histology. Methods As
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba81be394082ac54c2cf6c4b7c7e3f00
https://doi.org/10.1016/s1701-2163(15)30310-8
https://doi.org/10.1016/s1701-2163(15)30310-8
Autor:
Nereo Bon, Terence J. Colgan, Virginia Walley, Geoffrey Gardiner, Jeff Sumner, Susan Clipsham, C. Meg McLachlin
Publikováno v:
Cancer Cytopathology. 121:189-196
BACKGROUND: Studies of the performance of the automated FocalPoint Guided Screening (FPGS) imaging system in gynecologic cytology screening relative to manual screening have yielded conflicting results. In view of this uncertainty, a validation study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57a6d1c80586509c103be6f513910d7
https://doi.org/10.1002/cncy.21271
https://doi.org/10.1002/cncy.21271
Autor:
Marie-Hélène Mayrand, Alex Ferenczy, Eduardo L. Franco, Máire A. Duggan, Sam Ratnam, Walter H. Gotlieb, François Coutlée, Joseph E. Tota, James Bentley, Meg McLachlin, Michael Fung-Kee-Fung, Gina Ogilvie, Jennifer Blake, Joan Murphy
Publikováno v:
Preventive medicine. 98
Substantial evidence exists to support the introduction of molecular testing for human papillomavirus (HPV) as the primary technology in cervical cancer screening. While HPV testing is much more sensitive than cytology for detection of high-grade pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb56986381c6b6bddc565b772b802ac
https://pubmed.ncbi.nlm.nih.gov/28279257
https://pubmed.ncbi.nlm.nih.gov/28279257